GC Green Cross participates in CEPI pandemic preparedness exercise
GC Green Cross participated in a pandemic preparedness tabletop exercise organized by CEPI, testing their mRNA vaccine development capabilities within a 100-day timeframe.
GC Green Cross ships first anthrax vaccine 'Varitrax'
GC Green Cross has shipped its first anthrax vaccine 'Varitrax', co-developed with the Korea Disease Control and Prevention Agency, 8 months after approval.
GC Green Cross reported Q1 operating profit of 8 billion won, turning positive from a loss last year. Sales increased 7.6% to 383.8 billion won, driven by improved blood product profitability and global sales growth of high-margin products like Alliglo.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.